chr2-56184686-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001080433.2(CCDC85A):c.62C>T(p.Ala21Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000664 in 1,520,774 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A21S) has been classified as Uncertain significance.
Frequency
Consequence
NM_001080433.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CCDC85A | NM_001080433.2 | c.62C>T | p.Ala21Val | missense_variant | 1/6 | ENST00000407595.3 | |
LOC100129434 | NR_125368.1 | n.73+1012G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CCDC85A | ENST00000407595.3 | c.62C>T | p.Ala21Val | missense_variant | 1/6 | 1 | NM_001080433.2 | P1 | |
ENST00000668950.1 | n.173+1012G>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151800Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000621 AC: 7AN: 112758Hom.: 0 AF XY: 0.0000801 AC XY: 5AN XY: 62394
GnomAD4 exome AF: 0.0000694 AC: 95AN: 1368974Hom.: 0 Cov.: 35 AF XY: 0.0000696 AC XY: 47AN XY: 675302
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151800Hom.: 0 Cov.: 33 AF XY: 0.0000405 AC XY: 3AN XY: 74130
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2024 | The c.62C>T (p.A21V) alteration is located in exon 1 (coding exon 1) of the CCDC85A gene. This alteration results from a C to T substitution at nucleotide position 62, causing the alanine (A) at amino acid position 21 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at